Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis

    Glucagon-like peptide-1 receptor agonists (GLP1-ra) have shown to reduce cardiovascular (CV) events in patients with diabetes, including heart failure (HF) hospitalizations. However, whether such benefit consi...

    Alessandro Villaschi, Giuseppe Ferrante in Clinical Research in Cardiology (2024)

  2. No Access

    Article

    Double mutation in genes associated to FH and diabetes

    Susanna Longo, Francesca Cassandra, Iris Cardolini, Martina Montagna in Acta Diabetologica (2024)

  3. No Access

    Book and Reference Work

  4. No Access

    Reference Work Entry In depth

    Gut Microbiota and Type 2 Diabetes Mellitus

    Type 2 diabetes mellitus (T2DM) is characterized by poor insulin secretion from pancreatic beta cells together with reduced insulin sensitivity of adipose tissue, liver, and muscle. This results in an improper...

    Susanna Longo, Rossella Menghini in Gut Microbiome, Microbial Metabolites and … (2024)

  5. Article

    Open Access

    GLP-1RAs and cardiovascular disease: is the endothelium a relevant platform?

    Hyperglycemia strongly affects endothelial function and activation, which in turn increases the risk of atherosclerotic cardiovascular disease. Among pharmacotherapies aimed at lowering blood glucose levels, g...

    Rossella Menghini, Viviana Casagrande, Stefano Rizza in Acta Diabetologica (2023)

  6. Article

    Correction: The visceral adipose tissue bacterial microbiota provides a signature of obesity based on inferred metagenomic functions

    Jiuwen Sun, Alberic Germain, Gracia Kaglan in International Journal of Obesity (2023)

  7. No Access

    Article

    The visceral adipose tissue bacterial microbiota provides a signature of obesity based on inferred metagenomic functions

    Metabolic inflammation mediated obesity requires bacterial molecules to trigger immune and adipose cells leading to inflammation and adipose depot development. In addition to the well-established gut microbiot...

    Jiuwen Sun, Alberic Germain, Gracia Kaglan in International Journal of Obesity (2023)

  8. Article

    Open Access

    Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes

    The purpose of this review is to explore the interconnected pathways of the microbiota-gut-brain axis (MGBA), focusing on the roles of the vagus nerve and glucagon like peptide-1 in appetite control, and in th...

    Susanna Longo, Stefano Rizza, Massimo Federici in Acta Diabetologica (2023)

  9. Article

    Open Access

    Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial

    Despite paucity of data, it is common practice to discontinue metformin before invasive coronary angiography due to an alleged risk of Metformin-Associated Lactic Acidosis (M-ALA). We aimed at assessing the sa...

    Mauro Chiarito, Jorge Sanz-Sanchez, Raffaele Piccolo in Cardiovascular Diabetology (2023)

  10. No Access

    Book and Living Reference Work (Continuously updated edition)

  11. No Access

    Living Reference Work Entry In depth

    Gut Microbiota and Type 2 Diabetes Mellitus

    Type 2 diabetes mellitus (T2DM) is characterized by poor insulin secretion from pancreatic beta cells together with reduced insulin sensitivity of adipose tissue, liver, and muscle. This results in an improper...

    Susanna Longo, Rossella Menghini in Gut Microbiome, Microbial Metabolites and …

  12. Article

    Open Access

    Impact of light therapy on rotating night shift workers: the EuRhythDia study

    Disturbances in circadian rhythms may promote cardiometabolic disorders in rotating night shift workers (r-NSWs). We hypothesized that timed light therapy might reverse disrupted circadian rhythms and glucose ...

    Stefano Rizza, Alessio Luzi, Maria Mavilio, Marta Ballanti in Acta Diabetologica (2022)

  13. Article

    Open Access

    TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy

    Diabetic kidney disease, one of the most severe complications associated with diabetes, is characterized by albuminuria, glomerulosclerosis and progressive loss of renal function. Loss of TIMP3, an Extracellul...

    Viviana Casagrande, Massimo Federici, Rossella Menghini in Acta Diabetologica (2021)

  14. Article

    Open Access

    Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study

    To detect premature gluco-metabolic defects among night shift workers with disturbances in circadian rhythms.

    Stefano Rizza, Alessio Luzi, Maria Mavilio, Marta Ballanti in Acta Diabetologica (2021)

  15. Article

    Open Access

    The risk of carotid plaque instability in patients with metabolic syndrome is higher in women with hypertriglyceridemia

    Metabolic syndrome certainly favors growth of carotid plaque; however, it is uncertain if it determines plaque destabilization. Furthermore, it is likely that only some components of metabolic syndrome are ass...

    Francesca Servadei, Lucia Anemona, Marina Cardellini in Cardiovascular Diabetology (2021)

  16. No Access

    Article

    Venous distal bypass should be considered as the gold standard to finally attempt limb salvage in patients with severe critical limb ischemia and diabetic foot, or under dialysis

    Eugenio Martelli, Massimo Federici in Acta Diabetologica (2020)

  17. No Access

    Article

    Timp3 deficiency affects the progression of DEN-related hepatocellular carcinoma during diet-induced obesity in mice

    Obesity and low-grade inflammation are associated with an increased risk of hepatocellular carcinoma (HCC), a leading cause of cancer-related death worldwide. The tissue inhibitor of metalloproteinase (TIMP) 3...

    Viviana Casagrande, Alessandro Mauriello, Lucia Anemona in Acta Diabetologica (2019)

  18. Article

    Consider the microbiome in the equation! They were here before us...and hosted us!

    José-Manuel Fernández-Real, Massimo Federici in Reviews in Endocrine and Metabolic Disorde… (2019)

  19. No Access

    Article

    Gut microbiome and cardiometabolic risk

    The last decade has been characterized by an intense research on the composition of the gut microbiome and the links with human health. While previous work was focused on the effects of prebiotics and probioti...

    Ben Arpad Kappel, Massimo Federici in Reviews in Endocrine and Metabolic Disorders (2019)

  20. Article

    Our second genome and the impact on metabolic disorders: why gut microbiome is an important player in diabetes and associated abnormalities

    Massimo Federici in Acta Diabetologica (2019)

previous disabled Page of 2